GLP-1 / GIP Dual Agonist | 503A

Compounded Tirzepatide Injections for Weight Loss Clinics

Promise compounds Tirzepatide in multiple concentrations for medical weight loss clinics and telehealth providers. Available as standalone or with Glycine and B12. Shipped within 24-72 hours.

Dual GIP/GLP-1 Agonist
24-72 hr Ship Time
42 States
503A Compliant
Overview

What Is Compounded Tirzepatide?

Tirzepatide is a dual GIP and GLP-1 receptor agonist used in medically supervised weight management and metabolic health programs. It works on two incretin pathways simultaneously, which is why many clinics are adding it to their formulary alongside or as an alternative to Semaglutide. Promise compounds Tirzepatide in multiple strengths to support standard dose-escalation protocols, and offers combination formulations with Glycine (for injection site tolerance) and Methylcobalamin B12 (for metabolic support).

Clinical Use

Clinical Applications

Prescribers use compounded Tirzepatide for adult patients in structured weight management programs, often as a step-up from GLP-1 monotherapy or as a first-line dual-agonist option. Dose-escalation protocols follow a similar ramp-up structure to other GLP-1 therapies. Many clinics report that the dual-agonist mechanism supports broader metabolic outcomes beyond weight reduction alone. Promise supports clinics running Tirzepatide programs with fast fulfillment, consistent stock, and direct pricing.

Formulations

Tirzepatide Formulations Available

Formulation
Administration
Notes
Tirzepatide Injectable
Subcutaneous injection
Multiple concentrations for dose-escalation. Single and multi-dose vials.
Tirzepatide + Glycine + B12
Subcutaneous injection
Enhanced formulation. Glycine for injection site comfort, B12 for metabolic support.
Why Promise

Why Clinics Order Tirzepatide from Promise

Dual-Agonist Formulations In Stock. Both standalone Tirzepatide and the Glycine + B12 combination are available for immediate ordering.Consistent Supply. Tirzepatide availability has been inconsistent across the compounding market. Promise maintains stock to keep your patient protocols on schedule.Direct Pricing, No Broker Fees. Your Tirzepatide margins are protected by direct pharmacy pricing with no third-party commissions.Same-Portal Convenience. Order Tirzepatide alongside every other compound your clinic uses through one portal and one invoice.

Frequently Asked Questions

What is the difference between Tirzepatide and Semaglutide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two incretin pathways. Semaglutide is a GLP-1 receptor agonist that activates one. Both are used in medically supervised weight management programs. Your prescriber determines which is appropriate for each patient.

Does Promise offer the Tirzepatide + Glycine + B12 combination?

Yes. This is one of our most-ordered formulations. Glycine is added for injection site tolerance and B12 provides metabolic support within the same vial.

How fast can I get Tirzepatide shipped to my clinic?

Most Tirzepatide orders ship within 24-72 hours. Onboarding for new clinics takes 48 hours or less.

advanced 503A COMPOUNDING

One Pharmacy, One
Portal, For Any Clinic

A single access point for a wide range of 503A formulary products, catering to the requirements of any medical clinic, med spa, or telehealth provider.

Meet Our Team of Compounding Experts

At Promise Pharmacy, our dedicated team of hormone health specialists is led by Amy Patel, a seasoned expert in sterile compounding with more than 25 years of experience.

Dee Patel, PharmD
CEO
Amy Patel, Rph
COO
Amar Patel
CFO
Mike Patel
CRO
Rikin Patel
Director of Operations
Jacki
Pharmacy Development Director
Matt Orban
Director of Partnerships
Honey Arias
Success Manager
Learn More About Us
AVAILABILITY

Where we serve

Available
Pending
Unavailable
Wisconsin
Available
Wyoming
Available
West Virginia
Available
Washington
Available
Virginia
Pending
Vermont
Available
Texas
Unavailable
Utah
Available
Tennessee
Available
South Dakota
Available
South Carolina
Unavailable
Rhode Island
Available
Oklahoma
Available
Oregon
Available
Pennsylvania
Available
Ohio
Available
North Carolina
Available
North Dakota
Available
New York
Available
New Mexico
Available
New Jersey
Available
New Hampshire
Available
Nebraska
Available
Nevada
Available
Missouri
Available
Montana
Available
Mississippi
Unavailable
Michigan
Available
Massachusetts
Available
Maryland
Available
Maine
Available
Minnesota
Unavailable
Louisiana
Unavailable
Kentucky
Available
Kansas
Available
Indiana
Available
Iowa
Available
Illinois
Available
Idaho
Available
Hawaii
Available
District of Columbia
Available
Delaware
Available
Connecticut
Available
Georgia
Available
Florida
Available
Alaska
Available
Colorado
Available
Arizona
Available
Alabama
Unavailable
Arkansas
Unavailable
California
Unavailable